Literature DB >> 16369143

Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Ralf Dirk Rothoerl1, Cornelia Axmann, Ana-Luisa Pina, Chris Woertgen, Alexander Brawanski.   

Abstract

The delayed ischemic neurologic deficit (DIND) is a common and potentially devastating complication in patients who have sustained subarachnoid hemorrhage (SAH). Recent evidence suggests that various constituents of the inflammatory response may be critical in the pathogenesis of this ischemic complication. The aim of this study was to evaluate the possible relationship between the C-reactive protein (CRP)/white blood cell (WBC) count and DIND. A total of 88 patients with acute SAH were included. CRP and WBC count were estimated on a daily basis. Outcome was evaluated 1 year after the initial ictus according to the Glasgow Outcome Scale. CRP levels on days 5, 6, 7, and 8 were statistically significantly higher in the group of patients developing a DIND (P < 0.025, P < 0.016, P < 0.011, P < 0.0002). WBC counts were higher in this patient group on days 1, 4, 5, 6, and 7 (P < 0.0253, P < 0.0087, P < 0.00167, P < 0.0026, P < 0.0045). Overall CRP values were higher with increasing severity of the initial ictus according to the Hunt and Hess Scale and to the outcome according to the Glasgow Outcome Scale from day 3 on. A statistically significant relationship between WBCs and outcome could not be observed. The presented data do not prove that WBCs and CRP values have a direct contribution to the pathogenesis of ischemic complications following SAH, but it supports the assertion that inflammation may present a common pathogenic pathway in the development of such complications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16369143     DOI: 10.1097/01.ana.0000181693.30750.af

Source DB:  PubMed          Journal:  J Neurosurg Anesthesiol        ISSN: 0898-4921            Impact factor:   3.956


  21 in total

Review 1.  An introduction to the pathophysiology of aneurysmal subarachnoid hemorrhage.

Authors:  Jasper H van Lieshout; Maxine Dibué-Adjei; Jan F Cornelius; Philipp J Slotty; Toni Schneider; Tanja Restin; Hieronymus D Boogaarts; Hans-Jakob Steiger; Athanasios K Petridis; Marcel A Kamp
Journal:  Neurosurg Rev       Date:  2017-02-18       Impact factor: 3.042

2.  Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: exploratory analysis of CONSCIOUS-1 database.

Authors:  Alan K H Tam; Don Ilodigwe; Jay Mocco; Stephan Mayer; Neal Kassell; Daniel Ruefenacht; Peter Schmiedek; Stephan Weidauer; Alberto Pasqualin; R Loch Macdonald
Journal:  Neurocrit Care       Date:  2010-10       Impact factor: 3.210

3.  Statins and anti-inflammatory therapies for subarachnoid hemorrhage.

Authors:  Rajat Dhar; Michael Diringer
Journal:  Curr Treat Options Neurol       Date:  2012-04       Impact factor: 3.598

4.  Heart rate variability for preclinical detection of secondary complications after subarachnoid hemorrhage.

Authors:  J Michael Schmidt; Daby Sow; Michael Crimmins; David Albers; Sachin Agarwal; Jan Claassen; E Sander Connolly; Mitchell S V Elkind; George Hripcsak; Stephan A Mayer
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

5.  Elevated C-reactive protein and white blood cell count at admission predict functional outcome after non-aneurysmal subarachnoid hemorrhage.

Authors:  Patrick Schuss; Alexis Hadjiathanasiou; Simon Brandecker; Ági Güresir; Hartmut Vatter; Erdem Güresir
Journal:  J Neurol       Date:  2018-10-13       Impact factor: 4.849

Review 6.  The importance of early brain injury after subarachnoid hemorrhage.

Authors:  Fatima A Sehba; Jack Hou; Ryszard M Pluta; John H Zhang
Journal:  Prog Neurobiol       Date:  2012-03-10       Impact factor: 11.685

Review 7.  Unfractionated heparin: multitargeted therapy for delayed neurological deficits induced by subarachnoid hemorrhage.

Authors:  J Marc Simard; David Schreibman; E Francois Aldrich; Bernadette Stallmeyer; Brian Le; Robert F James; Narlin Beaty
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

8.  Hematologic counts as predictors of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

Authors:  Ivan Rocha Ferreira Da Silva; Joao Antonio Gomes; Ari Wachsman; Gabriel Rodriguez de Freitas; Jose Javier Provencio
Journal:  J Crit Care       Date:  2016-09-22       Impact factor: 3.425

9.  Significance of C-reactive protein and transcranial Doppler in cerebral vasospasm following aneurysmal subarachnoid hemorrhage.

Authors:  Sung-Hwan Hwang; Yong-Sook Park; Jeong-Taik Kwon; Taek-Kyun Nam; Sung-Nam Hwang; Hyun Kang
Journal:  J Korean Neurosurg Soc       Date:  2013-10-31

10.  The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage.

Authors:  Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2008       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.